Previously overlooked proteins are a potential source for a new class of cancer killing drugs

OICR-supported collaboration discovers new method to stunt the growth of brain cancers

New advances towards targeted therapies for triple negative breast cancer

Open source cancer research

The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research